These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 30739589)

  • 1. Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated With Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy.
    Cheedipudi SM; Matkovich SJ; Coarfa C; Hu X; Robertson MJ; Sweet M; Taylor M; Mestroni L; Cleveland J; Willerson JT; Gurha P; Marian AJ
    Circ Res; 2019 Apr; 124(8):1198-1213. PubMed ID: 30739589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA Damage Response/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated With LMNA (Lamin A/C) Mutations.
    Chen SN; Lombardi R; Karmouch J; Tsai JY; Czernuszewicz G; Taylor MRG; Mestroni L; Coarfa C; Gurha P; Marian AJ
    Circ Res; 2019 Mar; 124(6):856-873. PubMed ID: 30696354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA methylation analysis reveals epimutation hotspots in patients with dilated cardiomyopathy-associated laminopathies.
    Morival JLP; Widyastuti HP; Nguyen CHH; Zaragoza MV; Downing TL
    Clin Epigenetics; 2021 Jul; 13(1):139. PubMed ID: 34246298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrated analysis reveals the alterations that LMNA interacts with euchromatin in LMNA mutation-associated dilated cardiomyopathy.
    Zhang X; Shao X; Zhang R; Zhu R; Feng R
    Clin Epigenetics; 2021 Jan; 13(1):3. PubMed ID: 33407844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The LMNA mutation p.Arg321Ter associated with dilated cardiomyopathy leads to reduced expression and a skewed ratio of lamin A and lamin C proteins.
    Al-Saaidi R; Rasmussen TB; Palmfeldt J; Nissen PH; Beqqali A; Hansen J; Pinto YM; Boesen T; Mogensen J; Bross P
    Exp Cell Res; 2013 Nov; 319(19):3010-9. PubMed ID: 24001739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEAD1 trapping by the Q353R-Lamin A/C causes dilated cardiomyopathy.
    Yamada S; Ko T; Ito M; Sassa T; Nomura S; Okuma H; Sato M; Imasaki T; Kikkawa S; Zhang B; Yamada T; Seki Y; Fujita K; Katoh M; Kubota M; Hatsuse S; Katagiri M; Hayashi H; Hamano M; Takeda N; Morita H; Takada S; Toyoda M; Uchiyama M; Ikeuchi M; Toyooka K; Umezawa A; Yamanishi Y; Nitta R; Aburatani H; Komuro I
    Sci Adv; 2023 Apr; 9(15):eade7047. PubMed ID: 37058558
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Zaragoza MV; Bui TA; Widyastuti HP; Mehrabi M; Cang Z; Sha Y; Grosberg A; Nie Q
    Cells; 2024 Sep; 13(17):. PubMed ID: 39273049
    [No Abstract]   [Full Text] [Related]  

  • 8. Systematic in vivo candidate evaluation uncovers therapeutic targets for LMNA dilated cardiomyopathy and risk of Lamin A toxicity.
    Tan CY; Chan PS; Tan H; Tan SW; Lee CJM; Wang JW; Ye S; Werner H; Loh YJ; Lee YL; Ackers-Johnson M; Foo RSY; Jiang J
    J Transl Med; 2023 Oct; 21(1):690. PubMed ID: 37840136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lamin A/C haploinsufficiency causes dilated cardiomyopathy and apoptosis-triggered cardiac conduction system disease.
    Wolf CM; Wang L; Alcalai R; Pizard A; Burgon PG; Ahmad F; Sherwood M; Branco DM; Wakimoto H; Fishman GI; See V; Stewart CL; Conner DA; Berul CI; Seidman CE; Seidman JG
    J Mol Cell Cardiol; 2008 Feb; 44(2):293-303. PubMed ID: 18182166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and functional characterization of a novel mutation in lamin a/c gene in a multigenerational family with arrhythmogenic cardiac laminopathy.
    Forleo C; Carmosino M; Resta N; Rampazzo A; Valecce R; Sorrentino S; Iacoviello M; Pisani F; Procino G; Gerbino A; Scardapane A; Simone C; Calore M; Torretta S; Svelto M; Favale S
    PLoS One; 2015; 10(4):e0121723. PubMed ID: 25837155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterozygous LmnadelK32 mice develop dilated cardiomyopathy through a combined pathomechanism of haploinsufficiency and peptide toxicity.
    Cattin ME; Bertrand AT; Schlossarek S; Le Bihan MC; Skov Jensen S; Neuber C; Crocini C; Maron S; Lainé J; Mougenot N; Varnous S; Fromes Y; Hansen A; Eschenhagen T; Decostre V; Carrier L; Bonne G
    Hum Mol Genet; 2013 Aug; 22(15):3152-64. PubMed ID: 23575224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamin A/C mutations in dilated cardiomyopathy.
    Tesson F; Saj M; Uvaize MM; Nicolas H; Płoski R; Bilińska Z
    Cardiol J; 2014; 21(4):331-42. PubMed ID: 24846508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defects in nuclear structure and function promote dilated cardiomyopathy in lamin A/C-deficient mice.
    Nikolova V; Leimena C; McMahon AC; Tan JC; Chandar S; Jogia D; Kesteven SH; Michalicek J; Otway R; Verheyen F; Rainer S; Stewart CL; Martin D; Feneley MP; Fatkin D
    J Clin Invest; 2004 Feb; 113(3):357-69. PubMed ID: 14755333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct features of lamin A-interacting chromatin domains mapped by ChIP-sequencing from sonicated or micrococcal nuclease-digested chromatin.
    Lund EG; Duband-Goulet I; Oldenburg A; Buendia B; Collas P
    Nucleus; 2015; 6(1):30-9. PubMed ID: 25602132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear accumulation of androgen receptor in gender difference of dilated cardiomyopathy due to lamin A/C mutations.
    Arimura T; Onoue K; Takahashi-Tanaka Y; Ishikawa T; Kuwahara M; Setou M; Shigenobu S; Yamaguchi K; Bertrand AT; Machida N; Takayama K; Fukusato M; Tanaka R; Somekawa S; Nakano T; Yamane Y; Kuba K; Imai Y; Saito Y; Bonne G; Kimura A
    Cardiovasc Res; 2013 Aug; 99(3):382-94. PubMed ID: 23631840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic LMNA variants disrupt cardiac lamina-chromatin interactions and de-repress alternative fate genes.
    Shah PP; Lv W; Rhoades JH; Poleshko A; Abbey D; Caporizzo MA; Linares-Saldana R; Heffler JG; Sayed N; Thomas D; Wang Q; Stanton LJ; Bedi K; Morley MP; Cappola TP; Owens AT; Margulies KB; Frank DB; Wu JC; Rader DJ; Yang W; Prosser BL; Musunuru K; Jain R
    Cell Stem Cell; 2021 May; 28(5):938-954.e9. PubMed ID: 33529599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lamin A/C Ablation Restricted to Vascular Smooth Muscle Cells, Cardiomyocytes, and Cardiac Fibroblasts Causes Cardiac and Vascular Dysfunction.
    Del Monte-Monge A; Ruiz-Polo de Lara Í; Gonzalo P; Espinós-Estévez C; González-Amor M; de la Fuente-Pérez M; Andrés-Manzano MJ; Fanjul V; Gimeno JR; Barriales-Villa R; Dorado B; Andrés V
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative expression of the mutated lamin A/C gene in patients with cardiolaminopathy.
    Narula N; Favalli V; Tarantino P; Grasso M; Pilotto A; Bellazzi R; Serio A; Gambarin FI; Charron P; Meder B; Pinto Y; Elliott PM; Mogensen J; Bolognesi M; Bollati M; Arbustini E
    J Am Coll Cardiol; 2012 Nov; 60(19):1916-20. PubMed ID: 23062543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and ultrastructural studies in dilated cardiomyopathy patients: a large deletion in the lamin A/C gene is associated with cardiomyocyte nuclear envelope disruption.
    Gupta P; Bilinska ZT; Sylvius N; Boudreau E; Veinot JP; Labib S; Bolongo PM; Hamza A; Jackson T; Ploski R; Walski M; Grzybowski J; Walczak E; Religa G; Fidzianska A; Tesson F
    Basic Res Cardiol; 2010 May; 105(3):365-77. PubMed ID: 20127487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Target Genes and Transcription Factors in Mice with LMNA-Related Dilated Cardiomyopathy by Integrated Bioinformatic Analyses.
    Zhou H; Tan L; Lu T; Xu K; Li C; Liu Z; Peng H; Shi R; Zhang G
    Med Sci Monit; 2020 Jun; 26():e924576. PubMed ID: 32581210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.